Abstract:Objectives To select lactobacilli that inhibit Gardnerella vaginalis from vaginal secretions of healthy women and to lay the foundation for development of probiotics for use in treating bacterial vaginosis. Methods Vaginal swab samples were collected from 20healthy women of childbearing age and lactobacilli were isolated from those samples using De Man-Rogosa-Sharpe(MRS)medium.Strains of lactobacilli were grown in MRS broth for 24hat 37℃.Cell-free culture supernatant(CFCS)was obtained by centrifugation at 8,000r/min for 10min at 4℃.After the CFCS was centrifuged,it was passed through a sterile 0.22μm Millex GS filter unit.Lactobacillus strains were screened for antimicrobial activity by coculturing G.vaginalis ATCC 14018with CFCS.The suspension was spread on an agar plate to determine the number of viable bacteria according to the bacterial colony count.Selected strains were identified using physiological and biochemical tests,16SrDNA nucleotide sequencing,and a sugar fermentation test.Five mol/L NaOH was added to increase the pH of the CFCS to a pH of 7.0for another antibacterial test. Results The lactobacillus supernatant was tested for its inhibition of pathogens.Lactobacilli were examined for its antibacterial action against vaginal isolates of G. vaginalis.Antibacterial action was measured using the bacterial colony count 24hafter G.vaginalis was cocultured with CFCS.Results indicated that the CFCS reduced the viability of G.vaginalis with differing levels of effectiveness.Strains with the highest activity against G.vaginalis were 3,N7,and 15.The control had log 7.26CFU/ml of G.vaginalis. Adding CFCS to BHI broth containing strain 3resulted in log 5.09CFU/ml of G.vaginalis,adding CFCS to BHI broth containing strain N7resulted in log 5.42CFU/ml of G.vaginalis,and adding CFCS to BHI broth containing strain 15 resulted in log 5.44CFU/ml of G.vaginalis.Adding CFCS to BHI broth containing the commercial strain DM8909resulted in log 5.95CFU/ml of G.vaginalis.The 3strains had significantly greater antibacterial action than the commercial strain DM8909according to SPSS data analysis software(P0.05).Sugar fermentation testing yielded the same results as for Lactobacillus plantarum.The 16SrDNA gene analysis indicated 99% similarity to L.plantarumstrains in GenBank.The 3strains were identified as L.plantarum.When NaOH was added to increase the pH of the CFCS to a pH of 7.0,this resulted in log 7.5CFU/ml and log 7.6CFU/ml of G.vaginalis.There was almost no inhibitory action, suggesting that antibacterial action was mainly due to organic acids. Conclusion Three strains of L.plantarumstrongly inhibited G.vaginalis from vaginal secretions.These 3strains are likely candidates for use as probiotics for bacterial vaginosis.

Enhanced antifungal activity of bovine lactoferrin-producing probiotic Lactobacillus casei in the murine model of vulvovaginal candidiasis

Immunomodulatory Effects of L. Helveticus WHH2580 Fermented Milk on an Immunosuppressed Murine Model

Local Probiotic Lactobacillus Crispatus and Lactobacillus Delbrueckii Exhibit Strong Antifungal Effects Against Vulvovaginal Candidiasis in a Rat Model

Antifungal Effect of Long Noncoding RNA 9708-1 in the Vulvovaginal Candidiasis Murine Model

From whole genomes to probiotic candidates: A study of potential lactobacilli strains selection for vaginitis treatment

A New Approach for the Treatment of Recurrent Vulvovaginal Candidiasis with a Combination of Pea Protein, Grape Seed Extract, and Lactic Acid Assessed In Vivo

The preliminary study of antimicrobial activity of vaginal Lactobacillus isolated from healthy women

Characterization of a Lactobacillus gasseri strain as a probiotic for female vaginitis

Efficacy of Limosilactobacillus fermentum in the management of vulvovaginal candidiasis: comparative analysis with topical miconazole in a single-blind randomized clinical trial

Improved Treatment of Vulvovaginal Candidiasis with Clotrimazole Plus Probiotic Lacidophilin Vaginal Capsules: A Prospective, Real-World Study.

Synergistic Inhibition of Synbiotic Cultures among Lactobacilli and Plant Extracts against Vaginal Discharge Causing Candida albicans

Dysbiosis of the rat vagina is efficiently rescued by vaginal microbiota transplantation or probiotic combination

Inhibitory effects of vaginal Lactobacilli on C andida albicans growth, hyphal formation, biofilm development, and epithelial cell adhesion

The drug susceptibility in vitro of normal vaginal Lactobacillus to six different antifungal drugs

Bacillus coagulans LMG S-24828 Impairs Candida Virulence and Protects Vaginal Epithelial Cells against Candida Infection In Vitro

Clinical Study on Vulvovaginal Candidiasis by the Treatment Using Lactobacillus

Screening of lactobacilli for ability to inhibit Gardnerella vaginalis

Multifactorial inhibition of Candida albicans by combinations of lactobacilli and probiotic Saccharomyces cerevisiae CNCM I-3856

Vaginal Microbiota: Potential Targets for Vulvovaginal Candidiasis Infection.

Probiotic Interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the Opportunistic Fungal Pathogen Candida albicans

In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China